
Dr Swoboda on the Role of TKIs in Chronic Myeloid Leukemia
David M. Swoboda, MD, hematologist/oncologist, Tampa General Hospital Cancer Institute, discussed the roles of available TKIs for the treatment of patients with chronic myeloid leukemia (CML). Since the introduction of imatinib (Gleevec), which was the …